23andMe Holding Co. Files 8-K Report
| Field | Detail |
|---|---|
| Company | 23andme Holding Co. |
| Form Type | 8-K |
| Filed Date | Jun 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
TL;DR
23andMe filed an 8-K, mostly routine stuff, no major news yet.
AI Summary
On June 27, 2025, 23andMe Holding Co. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text. The company, formerly known as VG Acquisition Corp., is based in San Francisco, California.
Why It Matters
This 8-K filing indicates routine corporate reporting by 23andMe Holding Co., potentially related to ongoing financial disclosures or other corporate events.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without disclosure of significant negative events.
Key Players & Entities
- 23andMe Holding Co. (company) — Registrant
- VG Acquisition Corp. (company) — Former company name
- Virgin Group Acquisition Corp. (company) — Former company name
- Bleecker Street Acquisition Corp. (company) — Former company name
- June 27, 2025 (date) — Date of earliest event reported
- San Francisco, California (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for 23andMe Holding Co.?
The filing is for 'Other Events' and 'Financial Statements and Exhibits', indicating routine corporate reporting.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 27, 2025.
What are the principal executive offices of 23andMe Holding Co.?
The principal executive offices are located at 870 Market Street, Room 415, San Francisco, California 94102.
What were some of the former names of 23andMe Holding Co.?
The company was formerly known as VG Acquisition Corp., Virgin Group Acquisition Corp., and Bleecker Street Acquisition Corp.
What is the SIC code for 23andMe Holding Co.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 30, 2025 regarding 23andMe Holding Co..